Full Year 2025 Gubra A/S Earnings Call Transcript

Feb 27, 2026 / 09:00 AM GMT

Release Date Price: €50.8 (+12.09%)

Transcript

Key Points

Positve

Gubra AS (STU:PI3) reported record revenue of $400 million and an operating profit of $325 million for 2025.
The company successfully outlicensed its em compound to API, resulting in a significant upfront payment.
Gubra AS (STU:PI3) is expanding its facilities and workforce, currently employing around 300 people.
The company has a strong liquidity position and returned 1 billion Danish krona to shareholders as an extraordinary dividend.
Gubra AS (STU:PI3) is investing 10% of its pre-tax profits into green initiatives, demonstrating a commitment to ESG principles.

Negative

The CRO business experienced a decline compared to the previous year, attributed to challenges in the US funding environment for smaller biotech customers.
The company is investing in new areas like women's health and sarcopenia, which may not generate immediate earnings.
There is still market volatility, particularly in the US biotech segment, affecting decision cycles and order placements.
The EBIT margin for the CRO segment is expected to be lower in 2026 due to investments in new areas.
The ambitious clinical trial for UCN2 will increase spending in 2026, impacting short-term profitability.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GUBRA.CO - Gubra A/S
Full Year 2025 Gubra A/S Earnings Call
Feb 27, 2026 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the conference call. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answer session, participants are able to ask questions by dialing pound 5 on their telephone keypad. Now I will hand the conference over to the speakers. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning.

Welcome to the CR Investor Presentation. My name is Marcus Robert. I'm the CEO of CPR.

I'm joined here by, with, our, Chief Financial Officer, Christian, our Chief Scientific Officer, Luis, our Chief,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.